These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37777041)
1. Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure). Flett A; Cebula A; Nicholas Z; Adam R; Ewings S; Prasad S; Cleland JG; Eminton Z; Curzen N Am Heart J; 2023 Dec; 266():149-158. PubMed ID: 37777041 [TBL] [Abstract][Full Text] [Related]
2. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis. Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421 [TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis. Akel T; Lafferty J Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469 [TBL] [Abstract][Full Text] [Related]
4. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Stavrakis S; Asad Z; Reynolds D J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104 [TBL] [Abstract][Full Text] [Related]
5. MAgnetic resonance imaging based DUal lead cardiac Resynchronization therapy: A prospectIve Left Bundle Branch Pacing study (MADURAI LBBP study). Ponnusamy SS; Ganesan V; Ramalingam V; Syed T; Mariappan S; Murugan S; Kumar M; Anand V; Murugan M; Vijayaraman P Heart Rhythm; 2023 Aug; 20(8):1119-1127. PubMed ID: 37217065 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance. Champ-Rigot L; Gay P; Seita F; Benouda L; Morello R; Pellissier A; Alexandre J; Saloux E; Milliez P J Cardiovasc Magn Reson; 2020 Jun; 22(1):48. PubMed ID: 32580786 [TBL] [Abstract][Full Text] [Related]
7. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. Desai AS; Fang JC; Maisel WH; Baughman KL JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919 [TBL] [Abstract][Full Text] [Related]
8. Sudden cardiac death in nonischemic cardiomyopathy. Kadakia RS; Link MS; Dominic P; Morin DP Prog Cardiovasc Dis; 2019; 62(3):235-241. PubMed ID: 31075279 [TBL] [Abstract][Full Text] [Related]
9. Right Ventricular Dysfunction and the Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure. Elming MB; Hammer-Hansen S; Voges I; Nyktari E; Raja AA; Svendsen JH; Pehrson S; Signorovitch J; Køber LV; Prasad SK; Thune JJ Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007022. PubMed ID: 30866666 [TBL] [Abstract][Full Text] [Related]
10. [ECG score to predict ICD therapies in patients with nonischemic cardiomyopathy and primary prophylactic CRT-D]. Grett M; Christ M; Röing Gen Nölke JP; Trappe HJ Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):48-53. PubMed ID: 28204917 [TBL] [Abstract][Full Text] [Related]
11. Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy. Linhart M; Doltra A; Acosta J; Borràs R; Jáuregui B; Fernández-Armenta J; Anguera I; Bisbal F; Martí-Almor J; Tolosana JM; Penela D; Soto-Iglesias D; Villuendas R; Perea RJ; Ortiz JT; Bosch X; Auricchio A; Mont L; Berruezo A Europace; 2020 Sep; 22(9):1391-1400. PubMed ID: 32898254 [TBL] [Abstract][Full Text] [Related]
12. Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar. Gutman SJ; Costello BT; Papapostolou S; Voskoboinik A; Iles L; Ja J; Hare JL; Ellims A; Kistler PM; Marwick TH; Taylor AJ Eur Heart J; 2019 Feb; 40(6):542-550. PubMed ID: 30107489 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721 [TBL] [Abstract][Full Text] [Related]
14. Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale. Taborsky M; Skala T; Aiglova R; Fedorco M; Kautzner J; Jandik T; Vancura V; Linhart A; Valek M; Novak M; Kala P; Polasek R; Roubicek T; Schee A; Hindricks G; Dagres N; Hatala R; Jarkovsky J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):173-179. PubMed ID: 33724264 [TBL] [Abstract][Full Text] [Related]
15. Associations between scar characteristics by cardiac magnetic resonance and changes in left ventricular ejection fraction in primary prevention defibrillator recipients. Zhang Y; Guallar E; Weiss RG; Stillabower M; Gerstenblith G; Tomaselli GF; Wu KC Heart Rhythm; 2016 Aug; 13(8):1661-6. PubMed ID: 27108939 [TBL] [Abstract][Full Text] [Related]
16. Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week. Chrispin J; Merchant FM; Lakdawala NK; Wu KC; Tomaselli GF; Navara R; Torbey E; Ambardekar AV; Kabra R; Arbustini E; Narula J; Guglin M; Albert CM; Chugh SS; Trayanova N; Cheung JW J Am Coll Cardiol; 2023 Aug; 82(8):735-747. PubMed ID: 37587585 [TBL] [Abstract][Full Text] [Related]
17. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis. Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427 [TBL] [Abstract][Full Text] [Related]
18. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study. Singh B; Hsieh YC; Liu YB; Lin KH; Joung B; Rodriguez DA; Chasnoits AR; Huang D; Zhang S; O'Brien JE; Lexcen DR; Cerkvenik J; Van Dorn B; Ching CK Indian Heart J; 2023; 75(2):115-121. PubMed ID: 36736459 [TBL] [Abstract][Full Text] [Related]
19. Early Implantation of Primary Prevention Implantable Cardioverter Defibrillators for Patients with Newly Diagnosed Severe Nonischemic Cardiomyopathy. Voskoboinik A; Bloom J; Taylor A; Mariani J Pacing Clin Electrophysiol; 2016 Sep; 39(9):992-8. PubMed ID: 27343008 [TBL] [Abstract][Full Text] [Related]
20. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Wu KC; Gerstenblith G; Guallar E; Marine JE; Dalal D; Cheng A; Marbán E; Lima JA; Tomaselli GF; Weiss RG Circ Cardiovasc Imaging; 2012 Mar; 5(2):178-86. PubMed ID: 22267750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]